Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

A new dawn for Oxford BioMedica…again

This article was originally published in Scrip

Executive Summary

For Oxford BioMedica 2013 was quite an annus horribilis. However, the UK biotechnology firm is still confident it will rise up from the ashes this year – with CEO John Dawson saying that despite reporting pre-tax losses of more than £12m last year, the company is "operationally now in its strongest position ever."

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC025025

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel